HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anderson Ryan Selected Research

A-factor (Streptomyces)

12/2007Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic model of human non-small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anderson Ryan Research Topics

Disease

20Neoplasms (Cancer)
01/2022 - 12/2004
5Lung Neoplasms (Lung Cancer)
01/2021 - 11/2005
4Neoplasm Metastasis (Metastasis)
03/2012 - 01/2004
3Carcinoma (Carcinomatosis)
09/2009 - 05/2005
2Adenocarcinoma of Lung
01/2019 - 12/2007
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2012 - 12/2007
2Colorectal Neoplasms (Colorectal Cancer)
07/2010 - 11/2009
2Pleural Effusion (Pleural Effusions)
06/2008 - 12/2007
2Colonic Neoplasms (Colon Cancer)
11/2005 - 12/2004
2Glioblastoma (Glioblastoma Multiforme)
08/2005 - 01/2005
1Bites and Stings (Sting)
01/2022
1Alcoholism (Alcohol Abuse)
10/2017
1Hypersensitivity (Allergy)
10/2017
1Renal Cell Carcinoma (Grawitz Tumor)
12/2009
1Hepatocellular Carcinoma (Hepatoma)
09/2009
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
09/2009
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2009
1Breast Neoplasms (Breast Cancer)
08/2008
1Malignant Mesothelioma
06/2008
1Neuroblastoma
02/2008
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2005
1Neoplasm Micrometastasis
12/2005
1Papillary Thyroid Cancer
05/2005
1Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis)
05/2005
1Multiple Endocrine Neoplasia Type 2b (MEN 3)
05/2005
1Multiple Endocrine Neoplasia Type 2a (MEN 2)
05/2005
1Lewis Lung Carcinoma
05/2005
1Hypoxia (Hypoxemia)
01/2005
1Necrosis
01/2005
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2004

Drug/Important Bio-Agent (IBA)

12Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2012 - 05/2005
10vandetanib (ZD6474)IBA
11/2009 - 01/2004
8Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
03/2012 - 08/2005
6Phosphotransferases (Kinase)IBA
03/2012 - 05/2005
4Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
07/2010 - 08/2005
4ErbB Receptors (EGF Receptor)IBA
08/2008 - 08/2005
3cediranib (AZD2171)IBA
03/2012 - 09/2009
3Tyrosine (L-Tyrosine)FDA Link
03/2012 - 12/2005
3Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
09/2009 - 08/2005
2Biomarkers (Surrogate Marker)IBA
01/2019 - 12/2009
2Proteins (Proteins, Gene)FDA Link
03/2012 - 08/2005
2Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
07/2010 - 09/2009
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2009 - 05/2005
2Tyrosine Kinase InhibitorsIBA
06/2009 - 02/2008
2Epidermal Growth Factor (EGF)IBA
12/2007 - 12/2005
2N-acetylcochinol-O-phosphateIBA
01/2005 - 01/2004
1DNA (Deoxyribonucleic Acid)IBA
01/2022
1lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
01/2022
1pyridostatinIBA
01/2022
1Paclitaxel (Taxol)FDA LinkGeneric
01/2022
1Protein Kinases (Protein Kinase)IBA
01/2021
1Single-Stranded DNA (DNA, Single Stranded)IBA
01/2021
1Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
01/2019
1CollagenIBA
01/2019
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
10/2017
1Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2017
1Disulfiram (Antabuse)FDA Link
10/2017
1AcetaldehydeIBA
10/2017
1MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA
03/2012
1MitogensIBA
03/2012
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
03/2012
1AZD 6244IBA
03/2012
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
03/2012
1AntibodiesIBA
07/2010
1Irinotecan (Camptosar)FDA LinkGeneric
11/2009
1Phosphates (Orthophosphate)IBA
11/2009
1LigandsIBA
09/2009
1Vascular Endothelial Growth FactorsIBA
09/2009
1Mitogen-Activated Protein KinasesIBA
02/2008
1Bevacizumab (Avastin)FDA Link
02/2008
1Proto-Oncogene Proteins c-retIBA
02/2008
1Erlotinib Hydrochloride (CP 358,774)FDA Link
02/2008
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
02/2008
1Monoclonal AntibodiesIBA
02/2008
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
12/2007
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
12/2007
1A-factor (Streptomyces)IBA
12/2007
1IntegrinsIBA
11/2005
1Protein Isoforms (Isoforms)IBA
05/2005
1Angiogenesis InhibitorsIBA
05/2005
1Nitric Oxide Synthase (NO Synthase)IBA
01/2005
1Oxygen (Dioxygen)IBA
01/2005
1AZM475271IBA
12/2004
1src-Family KinasesIBA
12/2004
1GemcitabineFDA Link
12/2004

Therapy/Procedure

6Therapeutics
07/2010 - 11/2005
5Radiotherapy
11/2009 - 01/2005
2Drug Therapy (Chemotherapy)
01/2022 - 08/2005
2Aftercare (After-Treatment)
02/2008 - 11/2005
1Chemoradiotherapy
12/2007
1Withholding Treatment
08/2005
1Oral Administration
12/2004